We are live on
!
Find out more
GCM
Geneva Capital Management Portfolio holdings
AUM
$4.71B
1-Year Est. Return
6.32%
This Fund
S&P 500
This Quarter
Est. Return
+4.77%
1 Year Est. Return
+6.32%
3 Year Est. Return
+44.91%
5 Year Est. Return
+59.73%
10 Year Est. Return
–
AUM
$5.86B
AUM Growth
-$42.8M
(-0.72%)
Cap. Flow
-$217M
Cap. Flow
% of AUM
-3.71%
Top 10 Holdings %
Top 10 Hldgs %
20.97%
Holding
130
New
5
Increased
19
Reduced
104
Closed
2
Top Buys
| 1 |
BioLife Solutions
BLFS
|
+$40.8M |
| 2 |
QADA
QAD Inc.
QADA
|
+$28.1M |
| 3 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$25.1M |
| 4 |
Onto Innovation
ONTO
|
+$24.2M |
| 5 |
Globus Medical
GMED
|
+$20.4M |
Top Sells
| 1 |
IPHI
INPHI CORPORATION
IPHI
|
+$68.7M |
| 2 |
RP
RealPage, Inc.
RP
|
+$44.7M |
| 3 |
CMD
Cantel Medical Corporation
CMD
|
+$40.2M |
| 4 |
Monolithic Power Systems
MPWR
|
+$37.8M |
| 5 |
STAAR Surgical
STAA
|
+$34.9M |
Sector Composition
| 1 | Technology | 31.72% |
| 2 | Industrials | 22.87% |
| 3 | Healthcare | 20.34% |
| 4 | Consumer Discretionary | 9.47% |
| 5 | Financials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fox Factory Holding Corp
FOXF
$798M
| $147M | 2.51% |
1,156,076
-25,468
| -2% | -$3.29M |
|
2
Bio-Techne
TECH
$11.2B
| $137M | 2.34% |
1,433,696
-178,136
| -11% | -$16.3M |
|
3
Fair Isaac
FICO
$29.2B
| $131M | 2.24% |
269,871
-5,911
| -2% | -$2.81M |
|
4
BlackLine
BL
$1.78B
| $129M | 2.21% |
1,191,995
-50,108
| -4% | -$6.25M |
|
5
Exponent
EXPO
$3.05B
| $127M | 2.16% |
1,298,563
-28,374
| -2% | -$2.66M |
|
6
Omnicell
OMCL
$2.09B
| $116M | 1.97% |
889,707
-20,577
| -2% | -$2.64M |
|
7
Kinsale Capital Group
KNSL
$7.93B
| $113M | 1.93% |
687,686
-16,352
| -2% | -$3M |
|
8
Trex
TREX
$4.69B
| $113M | 1.92% |
1,231,339
-167,807
| -12% | -$15.8M |
|
9
Tyler Technologies
TYL
$13.1B
| $110M | 1.88% |
259,071
-8,998
| -3% | -$3.89M |
|
10
Bright Horizons
BFAM
$4.03B
| $106M | 1.81% |
619,054
-14,049
| -2% | -$2.31M |
|
|
MASI
11
DELISTED
Masimo
MASI
| $104M | 1.78% |
453,290
-87,998
| -16% | -$22.1M |
|
12
Alarm.com
ALRM
$2.63B
| $104M | 1.78% |
1,205,075
-25,869
| -2% | -$2.44M |
|
13
RBC Bearings
RBC
$18.2B
| $101M | 1.72% |
513,483
+35,889
| +8% | +$6.75M |
|
|
LHCG
14
DELISTED
LHC Group LLC
LHCG
| $100M | 1.71% |
524,886
+75,315
| +17% | +$15.1M |
|
|
15
STAAR Surgical
STAA
$1.32B
| $98.6M | 1.68% |
934,966
-348,267
| -27% | -$34.9M |
|
16
Allegiant Air
ALGT
$2.71B
| $91.2M | 1.56% |
373,789
-8,167
| -2% | -$1.81M |
|
17
SiteOne Landscape Supply
SITE
$4.6B
| $88.6M | 1.51% |
518,710
-11,398
| -2% | -$1.89M |
|
|
BCPC
18
Balchem Corp
BCPC
$5.25B
| $85.2M | 1.45% |
679,507
-14,170
| -2% | -$1.72M |
|
19
Descartes Systems
DSGX
$6.35B
| $82.1M | 1.4% |
1,348,337
-28,971
| -2% | -$1.76M |
|
20
Tactile Systems Technology
TCMD
$648M
| $80.2M | 1.37% |
1,471,527
-17,301
| -1% | -$927K |
|
21
ESCO Technologies
ESE
$8.25B
| $80.1M | 1.37% |
735,376
-13,530
| -2% | -$1.43M |
|
|
ENV
22
DELISTED
ENVESTNET, INC.
ENV
| $79.2M | 1.35% |
1,096,239
-27,682
| -2% | -$2.15M |
|
23
Texas Roadhouse
TXRH
$13B
| $79.1M | 1.35% |
824,845
-19,609
| -2% | -$1.71M |
|
|
24
Globus Medical
GMED
$10.5B
| $78.8M | 1.34% |
1,277,448
+322,334
| +34% | +$20.4M |
|
|
VCRA
25
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $75.9M | 1.3% |
1,973,455
-43,708
| -2% | -$1.88M |
|
Similar funds
AA
GCL
DCP
CCWM
KCM
BPCE
SCB
RS
Geneva Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Geneva Capital Management held 130 positions worth $5.86B, down 0.72% from $5.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Capital Management withdrew a net $217M in Q1 2021, closing 2 positions and reducing 104 holdings. Its most notable exit was RealPage, Inc., an estimated $44.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Geneva Capital Management opened a new position in BioLife Solutions worth $37.2M.
- Geneva Capital Management's largest Q1 2021 buy was BioLife Solutions: 1,033,095 shares worth $37.2M.
- Geneva Capital Management added most to QAD Inc. in Q1 2021, an estimated $28.1M increase.
- Geneva Capital Management's biggest Q1 2021 reduction was INPHI CORPORATION, cutting an estimated $68.7M.
- Geneva Capital Management fully exited RealPage, Inc. in Q1 2021, selling an estimated $44.7M.
- Geneva Capital Management's ten largest holdings make up 21% of its $5.86B portfolio in Q1 2021.
- Geneva Capital Management opened 5 new positions and closed 2 in Q1 2021.
- Geneva Capital Management's portfolio value fell 0.72% quarter-over-quarter to $5.86B.
Based on Geneva Capital Management's 13F filing for Q1 2021, filed 3 May 2021.